Amended Current Report Filing (8-k/a)
06 Abril 2021 - 6:06PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
March 19, 2021
SYSOREX, INC.
(Exact name of registrant as specified in its charter)
Nevada
|
|
000-55924
|
|
68-0319458
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
13880 Dulles Corner Lane
Suite 175
Herndon, Virginia
|
|
20171
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including
area code: 800-929-3871
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously
satisfy the filing obligation of the Registrant under any of the following provisions:
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
|
|
Trading Symbol
|
|
Name of Each Exchange on Which
Registered
|
N/A
|
|
N/A
|
|
N/A
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Explanatory Note
On March 25, 2021, Sysorex,
Inc. (the “Company”) filed with the Securities and Exchange Commission (“SEC”) a Current Report on Form 8-K (the
“Initial Report”) for the purpose of announcing its entry into a Letter Agreement dated March 19, 2021 (the “Letter
Agreement”) with First Choice International Company, Inc. (“Lender”) providing for the advance payment by the Lender
of $2,000,000 (the “Advance” or “Principal Amount”) to Systat Software, Inc. (“Systat”) on behalf of the Company. The purpose of
this amendment to the Initial Report is to announce the completion of a definitive loan agreement between the Company and First Choice
pertaining to repayment of the Advance.
|
Item
1.01
|
Entry
into a Material Definitive Agreement.
|
On March 31, 2021, the Company
and the Lender entered into a Commercial Loan Agreement (“Loan Agreement”) and Promissory Note (“Note”) (collectively,
the “Loan Documents”). Under the terms of the Note, the Company must repay the Principal Amount plus any accrued and unpaid
interest as a balloon payment no later than June 30, 2021. Interest under the Note will accrue monthly at a rate of one percent (1%) per
month (“Interest”) on the outstanding Principal Amount payable Interest only on the 28th day of each month.
On March 19, 2021, pursuant
to the Letter Agreement, and as a condition of the Advance, Systat assigned to Lender that certain Secured Promissory Note of the Company
in the principal amount of $3,000,000 with an issuance date of June 30, 2020 (the “Indebtedness”). Pursuant to the Loan Agreement,
the Company and Lender have agreed that the Indebtedness shall be cancelled in exchange for the issuance of 5,272,408 shares (“Pledged
Shares”) of the Company’s Common Stock, which Pledged Shares shall be held in escrow by the Company’s transfer agent
as collateral to secure the repayment obligations owed under the Loan Documents. In connection therewith, and prior to issuance of the
Pledged Shares, the Company and the Lender entered into a Stock Pledge Agreement dated as of March 31, 2021 (the “Pledge Agreement”)
providing for the pledge of the Pledged Shares to secure full and punctual payment and discharge of the Note, and all accrued or unpaid
Interest and fees under the Loan Documents. The Company and the Lender are continuing to negotiate the terms of a Securities Settlement
Agreement (“SSA”), which will set forth the terms and conditions regarding when the Pledged Shares shall be issued or become
issuable.
Pursuant to the Loan Documents,
upon the full and timely repayment of the Principal Amount and all accrued or unpaid Interest and fees, the Lender has agreed that the
Pledged Shares shall be deemed returned to the Company and cancelled in full. If the Note is not timely repaid and there is a continuing
Event of Default, which cannot be cured, the Pledged Shares shall be timely released to the Lender. Should the Lender achieve repayment
from sale of the Pledged Shares including all accrued or unpaid Interest and fees under the Loan Documents, the Note shall be discharged.
Until the Note has been discharged, the Lender shall have all other rights available to it as a debtholder in accordance with the Loan
Documents, at law and in accordance with principles of equity.
The above summaries of the
Loan Agreement, Note, and Pledge Agreement are not intended to be complete, and are qualified in their entirety by reference to the full
text of the Loan Agreement and Note, and Pledge Agreement, copies of which are filed herewith as Exhibits 10.1 and 10.2, respectively,
and which are incorporated herein by reference.
|
Item 2.03
|
Creation of Direct Financial Obligation or an Obligation
under an Off-Balance Sheet Arrangement of a Registration.
|
The information set forth
in Item 1.01 of this Current Report on Form 8-K, to the extent required by this Item 2.03, is incorporated herein by reference.
|
Item
3.02
|
Unregistered
Sales of Equity Securities.
|
The
information set forth in Item 1.01 of this Current Report on Form 8-K, to the extent required by this Item 3.02, is incorporated herein
by reference. The Shares of common stock that may be issued pursuant to the Pledge Agreement will be sold and issued without registration
under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on the exemptions provided by Section 4(a)(2)
of the Securities Act as transactions not involving a public offering and/or Rule 506 promulgated under the Securities Act as sales to
an accredited investor, and in reliance on similar exemptions under applicable state laws.
The
Company currently has 494,311 shares of common stock outstanding, excluding any shares that may be issued pursuant to the Pledge Agreement
and SSA or previously disclosed pledge arrangements.
|
Item
9.01
|
Financial
Statements and Exhibits.
|
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
SYSOREX, INC.
|
|
|
Date: April 6, 2021
|
By:
|
/s/
Zaman Khan
|
|
Name:
|
Zaman Khan
|
|
Title:
|
Chief Executive Officer
|
4
Sysorex (CE) (USOTC:SYSX)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Sysorex (CE) (USOTC:SYSX)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025